Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 10:01 am Purchase | 2024-09-30 | 13G | BIORA THERAPEUTICS INC PAR BIORQ | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 19,958,480 9.990% | 19,958,480 (New Position) | Filing History |
| 2024-10-09 5:40 pm Purchase | 2024-10-07 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 2,574,453 49.900% | 30,716 (+1.21%) | Filing History |
| 2024-09-13 10:37 am Unchanged | 2024-09-10 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 2,543,737 49.900% | 0 (Unchanged) | Filing History |
| 2024-08-20 4:15 pm Purchase | 2023-12-19 | 13G | Biora Therapeutics, Inc. BIOR | Davidson Kempner Capital Management LP | 3,731,590 9.900% | 3,731,590 (New Position) | Filing History |
| 2024-08-14 9:58 pm Purchase | 2024-08-12 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 2,543,737 49.900% | 58,291 (+2.35%) | Filing History |
| 2024-07-08 9:42 pm Purchase | 2024-07-03 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 2,485,446 49.900% | 2,485,446 (New Position) | Filing History |
| 2024-04-02 8:43 pm Purchase | 2024-03-31 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 1,930,628 49.900% | 309,176 (+19.07%) | Filing History |
| 2024-03-20 6:29 pm Purchase | 2024-03-12 | 13G | Biora Therapeutics, Inc. BIOR | Context Capital Management LLC | 298,970 9.900% | 298,970 (New Position) | Filing History |
| 2024-02-14 2:43 pm Purchase | 2023-12-31 | 13G | Biora Therapeutics, Inc. BIOR | ARMISTICE CAPITAL LLC | 107,490 3.800% | 107,490 (New Position) | Filing History |
| 2023-12-20 4:35 pm Purchase | 2023-12-18 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 1,621,453 49.900% | 386,569 (+31.30%) | Filing History |
| 2023-09-19 4:15 pm Purchase | 2023-09-18 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 1,234,884 49.900% | 867,926 (+236.52%) | Filing History |
| 2023-03-13 4:18 pm Purchase | 2023-03-10 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 366,958 32.700% | 82,414 (+28.96%) | Filing History |
| 2023-02-14 12:05 pm Purchase | 2022-12-31 | 13G | Biora Therapeutics, Inc. BIOR | ARMISTICE CAPITAL LLC | 1,298,965 5.700% | 1,298,965 (New Position) | Filing History |
| 2023-01-12 4:46 pm Sale | 2023-01-03 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 284,544 27.800% | -177,555,628 (-99.84%) | Filing History |
| 2022-11-18 4:30 pm Purchase | 2022-11-09 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 177,840,173 28.400% | 10,022,310 (+5.97%) | Filing History |
| 2022-02-14 3:32 pm Sale | 2021-12-31 | 13G | Biora Therapeutics, Inc. BIOR | CVI Investments, Inc. | 9,375,000 2.200% | -21,243,073 (-69.38%) | Filing History |
| 2021-11-26 4:45 pm Purchase | 2021-11-24 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Opportunities 2020 LP | 167,817,863 31.100% | 167,817,863 (New Position) | Filing History |
| 2021-08-30 10:15 am Purchase | 2021-08-19 | 13G | Biora Therapeutics, Inc. BIOR | CVI Investments, Inc. | 30,618,073 9.900% | 30,618,073 (New Position) | Filing History |
| 2021-08-27 4:22 pm Unchanged | 2021-08-24 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Capital Management LP | 184,170,513 47.000% | 0 (Unchanged) | Filing History |
| 2021-06-21 4:32 pm Purchase | 2021-06-01 | 13D | Biora Therapeutics, Inc. BIOR | Athyrium Capital Management LP | 184,170,513 64.200% | 43,656,118 (+31.07%) | Filing History |